✦ LIBER ✦

Cetuximab alone or in combination with irinotecan effective against irinotecan-refractory colorectal cancer

✍ Scribed by Les Lang

Book ID: 119758040
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 51 KB
Volume: 127
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2004.08.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cetuximab Monotherapy and Cetuximab plus

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

✍ Cunningham, David; Humblet, Yves; Siena, Salvatore; Khayat, David; Bleiberg, Har 📂 Article 📅 2004 🏛 Massachusetts Medical Society 🌐 English ⚖ 129 KB

MDR1polymorphism role in patients treate

MDR1polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer

✍ Bernard Paule; Vincent Castagne; Véronique Picard; Raphaël Saffroy; René Adam; C 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 210 KB

Pharmacogenetic Profiling for Cetuximab

Pharmacogenetic Profiling for Cetuximab Plus Irinotecan Therapy in Patients With Refractory Advanced Colorectal Cancer

✍ Graziano, F.; Ruzzo, A.; Loupakis, F.; Canestrari, E.; Santini, D.; Catalano, V. 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 127 KB

Capecitabine in Combination with Irinote

Capecitabine in Combination with Irinotecan or Oxaliplatin in Advanced Colorectal Cancer

✍ Amy D'Orazio; M. Sitki Copur; Edward Chu 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 105 KB

1086 Cetuximab in a randomized phase II

1086 Cetuximab in a randomized phase II trial as a single agent or in combination with irinotecan in patients with epidermal growth factor receptor (EGFR)-expressing, irinotecan-refractory metastatic colorectal cancer (CRC)

✍ Van Cutsem, E.; Gascón Vilaplana, P.; Seitz, J.F.; Van Laethem, J.L.; Grossi, F. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Correlation Between the Response to Cetu

Correlation Between the Response to Cetuximab Alone or in Combination With Irinotecan and the Activated/Phosphorylated Epidermal Growth Factor Receptor in Metastatic Colorectal Cancer

✍ Nicola Personeni; Alain Hendlisz; Julien Gallez; Maria Gomez Galdon; Denis Larsi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 96 KB